Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David P Nichols, MD
National Jewish Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
39 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- Rady Children'S Hospital and Health Center at the University of California San Diego
San Diego, California, United States
- National Jewish Health
Denver, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- the Nemours Children'S Clinic - Orlando
Orlando, Florida, United States
- Nemours Children'S Clinic - Pensacola
Pensacola, Florida, United States
- Saint Luke'S Cystic Fibrosis Center of Idaho
Boise, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- Saint Francis Medical Center
Peoria, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Maine Medical Partners Pediatric Specialty Care
Portland, Maine, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- University of Massachusetts Memorial Health Care
Worcester, Massachusetts, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Helen Devos Children'S Hospital
Grand Rapids, Michigan, United States
- the Minnesota Cystic Fibrosis Center
Minneapolis, Minnesota, United States
- Children'S Mercy Kansas City
Kansas City, Missouri, United States
- Cardinal Glennon Children'S Medical Center
St Louis, Missouri, United States
- St. Louis Children'S Hospital
St Louis, Missouri, United States
- Monmouth Medical Center
Long Branch, New Jersey, United States
- Beth Israel Medical Center
New York, New York, United States
- Children'S Hospital of New York
New York, New York, United States
- University of Rochester Medical Center Strong Memorial
Rochester, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- University Hospitals Case Medical Center/rainbow Babies and Children'S Hospital
Cleveland, Ohio, United States
- Dayton Children'S Hospital
Dayton, Ohio, United States
- Oregon Health Sciences University
Portland, Oregon, United States
- Hershey Medical Center Pennsylvania State University
Hershey, Pennsylvania, United States
- St. Christopher'S Hospital for Children
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Intermountain Cystic Fibrosis Center
Salt Lake City, Utah, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
- University of Washington Medical Center
Seattle, Washington, United States
- Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Oct 2016
- Primary completion
- 13 Feb 2020
- Completion
- 13 Feb 2020
- Last update posted
- 28 Jun 2021
- Registered enrollment
- 119
- Registry id
- NCT02677701
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.